Home > Innovation Offerings > Research Capabilities

Research Capabilities

A*STAR provides the ideal environment to push the frontiers of science and engage in world-class research that will benefit the Singapore economy and society at large. Scientists can exploit a world-class research infrastructure at Biopolis and Fusionopolis, the twin biomedical sciences and physical sciences & engineering research hubs at one-north that provide a conducive environment in which to live, work, play and learn.
 
Each of A*STAR’s research units has a particular research focus geared towards producing economic outcomes for Singapore. They are supported by the Biomedical Research Council (BMRC) and Science and Engineering Research Council (SERC), which chart the research directions of A*STAR and spearhead it for success.
 
The Biomedical Research Council (BMRC) continues to build up considerable strength in six key research areas, namely:
    • molecular, cellular and developmental biology
    • cancer genetics
    • stem cells and regenerative medicine
    • immunology and infectious disease
    • metabolic medicine
    • biomedical engineering
 
The BMRC research units have also established a number of internationally-competitive technological platforms which help scientists to advance their research. The core technological platforms include genomics and proteomics, structural biology, bioinformatics and bioimaging.
 
Innovation in the Science and Engineering Research Council (SERC) is supported by an assembly of capabilities that include:
    • Computational and Device Technologies
    • Materials and Chemistry
    • Mechatronics & Automation
    • Manufacturing Technologies
    • Information, Communications, Media
    • Metrology
 
Furthermore, while Chemistry has always been a critical enabler for Biomedical Science, SERC has begun to extend physics and engineering principles and methodology to the biomedical sciences, thus creating new capabilities in Bio-Technology.
 
 
Email us (tech-offer@etpl.sg) with your inquiry now.